P2.03-023 Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic
Skrickova, J., Chloupkova, R., Bortlicek, Z., Pesek, M., Kolek, V., Hejduk, K., Koubkova, L., Cernovska, M., Krejci, J., Zemanová, M., Havel, L., Roubec, J., Hrnciarik, M., Salajka, F., Coupkova, H.,Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.1274
Date:
November, 2017
File:
PDF, 281 KB
english, 2017